Michael Fähling Selected Research

Tissue Inhibitor of Metalloproteinase-2

10/2004

Regulation of collagen prolyl 4-hydroxylase and matrix metalloproteinases in fibrosarcoma cells by hypoxia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Fähling Research Topics

Disease

11	Hypoxia (Hypoxemia) 10/2022 - 10/2004
7	Neoplasms (Cancer) 06/2022 - 10/2005
3	Neuroblastoma 01/2016 - 01/2011
3	Fibrosarcoma 04/2006 - 10/2004
2	Hypertension (High Blood Pressure) 01/2019 - 08/2008
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2011 - 02/2009
2	Fibrosis (Cirrhosis) 10/2005 - 10/2004
1	Anemia 10/2022
1	Microvascular Rarefaction 10/2022
1	Liver Neoplasms (Liver Cancer) 06/2022
1	Hepatoblastoma 06/2022
1	COVID-19 10/2021
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 12/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Frontotemporal Dementia (Semantic Dementia) 01/2018
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2018
1	Acute Kidney Injury (Acute Renal Failure) 01/2017
1	Atherosclerosis 02/2014
1	Brain Neoplasms (Brain Tumor) 01/2014
1	Glioma (Gliomas) 01/2014
1	Rhabdomyolysis 11/2013
1	Necrosis 11/2013
1	Brain Diseases (Brain Disorder) 03/2012
1	Kidney Diseases (Kidney Disease) 03/2011
1	Lung Neoplasms (Lung Cancer) 01/2011
1	Temporal Lobe Epilepsy 09/2009
1	Intellectual Disability (Idiocy) 02/2009
1	Fragile X Syndrome (Martin Bell Syndrome) 02/2009
1	Wilms Tumor (Wilm's Tumor) 08/2008
1	Arthritis (Polyarthritis) 10/2005
1	Neoplasm Metastasis (Metastasis) 10/2005

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2005
4	Oxygen (Dioxygen)IBA 10/2021 - 09/2006
4	Messenger RNA (mRNA)IBA 03/2015 - 09/2006
3	Basic Helix-Loop-Helix Transcription FactorsIBA 01/2016 - 02/2009
3	Transcription Factors (Transcription Factor)IBA 03/2015 - 01/2011
3	IronIBA 01/2011 - 10/2005
3	CollagenIBA 09/2006 - 10/2004
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2022 - 01/2019
2	Histone Deacetylases (Histone Deacetylase)IBA 06/2022 - 12/2019
2	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 11/2013
2	EnzymesIBA 12/2019 - 10/2004
2	Caspase 3 (Caspase-3)IBA 01/2019 - 11/2013
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2011
2	RNA (Ribonucleic Acid)IBA 01/2018 - 03/2012
2	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 09/2014 - 01/2011
2	Glycine Receptors (Glycine Receptor)IBA 01/2014 - 09/2009
2	NucleolinIBA 01/2011 - 09/2006
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 09/2006 - 10/2004
2	Chelating AgentsIBA 04/2006 - 10/2005
2	2,2'-Dipyridyl (2,2 Bipyridine)IBA 04/2006 - 10/2005
2	Matrix Metalloproteinases (MMPs)IBA 10/2005 - 10/2004
1	GSK1278863IBA 10/2022
1	Hemoglobins (Hemoglobin)IBA 10/2022
1	Tubulin ModulatorsIBA 06/2022
1	TubulinIBA 06/2022
1	Gentian Violet (Violet, Crystal)FDA Link 06/2022
1	Antineoplastic Agents (Antineoplastics)IBA 06/2022
1	PlatinumIBA 12/2019
1	animacroxamIBA 12/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2019
1	Histone Deacetylase InhibitorsIBA 12/2019
1	Angiotensin IIIBA 01/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	StaurosporineIBA 01/2019
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 01/2018
1	Contrast MediaIBA 01/2017
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2016
1	RibonucleoproteinsIBA 03/2015
1	hnRNP A2IBA 09/2014
1	ApolipoproteinsIBA 02/2014
1	Apolipoproteins E (ApoE)IBA 02/2014
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2014
1	Ligand-Gated Ion ChannelsIBA 01/2014
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2014
1	Nuclear Localization Signals (Nuclear Localization Signal)IBA 01/2014
1	Protons (Proton)IBA 11/2013
1	CreatinineIBA 11/2013
1	Urea (Carbamide)FDA LinkGeneric 11/2013
1	Untranslated RNA (Noncoding RNA)IBA 03/2012
1	DNA Transposable Elements (Element, IS)IBA 03/2012
1	Retroelements (Retrotransposon)IBA 03/2012
1	Endothelin-1 (Endothelin 1)IBA 03/2011
1	Carrier Proteins (Binding Protein)IBA 01/2011
1	ElementsIBA 01/2011
1	AntigensIBA 01/2011
1	Polypyrimidine Tract-Binding ProteinIBA 01/2011
1	TristetraprolinIBA 01/2011
1	phorbolIBA 01/2011
1	glycine receptor alpha3 subunitIBA 09/2009
1	Adenosine Triphosphate (ATP)IBA 09/2009
1	Fragile X Mental Retardation ProteinIBA 02/2009
1	ReninIBA 08/2008
1	Amino Acids FDA Link 08/2008
1	3' Untranslated Regions (3' UTR)IBA 09/2006
1	Tissue Inhibitor of Metalloproteinase-1IBA 10/2004
1	Tissue Inhibitor of Metalloproteinase-2IBA 10/2004
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 10/2004

Therapy/Procedure

3	Therapeutics 12/2019 - 01/2014